CClinicalTrials.gg
Sign In
CompletedNCT00224159Updated Feb 21, 2011

Does Statin Initiation Undermine Dietary Behavior?

An observational study in All English Speaking Adults From the Manhattan VA Clinic Who Have Recently Received Their First Prescription for a Statin, sponsored by Weill Medical College of Cornell University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-02-21.

Sponsored by Weill Medical College of Cornell University · Observational

Study type
Observational
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research is to improve our understanding of the effects that taking cholesterol reducing pills have on dietary behavior as well as other health related behaviors

Read the detailed description

This study explores the impact of initiating statin therapy on subsequent dietary as well as other lifestyle beliefs, attitudes and behaviors.

Specific aims:

  1. To test whether the initiation of statin therapy increases dietary saturated fat intake among statin naive patients.
  2. To determine what role attitudes, beliefs, expectations, motivation, intention and self-efficacy regarding drug or diet therapy may play in observed changes in dietary behavior after starting statin therapy.
02

Conditions studied

  • All English Speaking Adults From the Manhattan VA Clinic Who Have Recently Received Their First Prescription for a Statin

Keywords

  • Statin therapy
  • Dietary behavior
  • Attitudes and beliefs
  • Self efficacy
03

In context

Lead sponsor

Weill Medical College of Cornell University is the lead sponsor of 867 studies on the registry; 160 are open to participants now.

Of its 119 completed or terminated interventional studies of FDA-regulated products, 91 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All English-speaking adults who have recently (within 1 week)received their first prescription for a statin will be eligible.

Inclusion criteria

All English-speaking adults who have recently (within 1 week)received their first prescription for a statin will be eligible.

Exclusion criteria

Exclusion Criteria:

Will include a history of any of the following:

  1. Prior CVD (myocardial infarction, angina, angioplasty, stroke, CABG. or arterial bypass surgery)
  2. Diabetes patients
  3. Psychiatric patients
  4. AIDS patients
  5. Substance abuse patients
  6. Prior cholesterol lowering medication use
  7. Inability to complete the interviews
05

Study design

Enrollment
100 participants

Interventions

  • BehavioralDrug and Dietary behavior
06

What researchers measure

Primary outcomes

  1. How drug or dietary therapy may play a role in dietary behavior.

07

Study locations

1 site
  • The New York Presbyterian Hospital-Weill Medical Center
    New York, New York 10021, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00224159
Lead sponsor
Weill Medical College of Cornell University
Collaborators
Agency for Healthcare Research and Quality (AHRQ)
First posted
Sep 22, 2005
Start date
Feb 2005
Completion
Jun 2006
Last update
Feb 21, 2011

Study contacts

Sundar Natarajan, MD, MSc
principal investigator · Weill Medical College of Cornell University
Devin Mann, MD
principal investigator · Weill Medical College of Cornell University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Weill Medical College of Cornell University

Start the discussion